Virtual Reality Mindfulness Meditation for Anterior Cruciate Ligament Injury

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Fetzer Hall, 210 South Road, Chapel Hill, NC
Anterior Cruciate Ligament Injury+1 More
Virtual Reality Mindfulness Meditation - Behavioral
Eligibility
< 65
Female
What conditions do you have?
Select

Study Summary

To evaluate the effect of virtual reality mindfulness meditation on patients after ACLR, the investigators will determine the effect of virtual reality mindfulness meditation to 1) decrease self-reported injury-related fear, 2) improve poor jump-landing movement patterns, and 3) improve brain activity in women 1 to 5 years post-ACLR when compared to a virtual reality sham group.

Eligible Conditions

  • Anterior Cruciate Ligament Injury

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Anterior Cruciate Ligament Injury

Study Objectives

4 Primary · 3 Secondary · Reporting Duration: Through study completion, a total of approximately 3 years.

Week 8
Change in Injury-related fear as measured by the Tampa Scale of Kinesiophobia-11
Change in Mean percent Blood Oxygen Level Dependent signal in Default Mode Network.
Change in external knee abduction moment
Change in knee flexion excursion
Week 8
Mean Acceptability Survey Score
Year 3
Percentage of participants who were eligible and enrolled in the study
Through study completion, a total of approximately 8-weeks
Percentage of participants retained in the study

Trial Safety

Safety Progress

1 of 3

Other trials for Anterior Cruciate Ligament Injury

Trial Design

2 Treatment Groups

VR Mindfulness Meditation Group
1 of 2
VR Sham Group
1 of 2
Experimental Treatment
Non-Treatment Group

48 Total Participants · 2 Treatment Groups

Primary Treatment: Virtual Reality Mindfulness Meditation · Has Placebo Group · N/A

VR Mindfulness Meditation Group
Behavioral
Experimental Group · 1 Intervention: Virtual Reality Mindfulness Meditation · Intervention Types: Behavioral
VR Sham Group
Behavioral
ShamComparator Group · 1 Intervention: Virtual Reality Sham · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, a total of approximately 3 years.
Closest Location: Fetzer Hall, 210 South Road · Chapel Hill, NC
N/AFirst Recorded Clinical Trial
1 TrialsResearching Anterior Cruciate Ligament Injury
0 CompletedClinical Trials

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,348 Previous Clinical Trials
3,908,558 Total Patients Enrolled
1 Trials studying Anterior Cruciate Ligament Injury
102 Patients Enrolled for Anterior Cruciate Ligament Injury
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
443 Previous Clinical Trials
1,069,483 Total Patients Enrolled
4 Trials studying Anterior Cruciate Ligament Injury
1,376 Patients Enrolled for Anterior Cruciate Ligament Injury
Shelby E Baez, Ph.D., ATCPrincipal InvestigatorUNC-Chapel Hill

Eligibility Criteria

Age < 65 · Female Participants · 9 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are female.\n
You have self-reported levels of fear on the Tampa Scale of Kinesiophobia-11.
You have poor jump-landing movement quality as measured by the Landing Error Scoring System-Real Time.
You have injured your knee playing or training for sports.
You have had an ACLR at least 1 to 5 years post-surgery.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.